Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung, Karel Erion, José C. Florez, et al.
Diabetologia (2020) Vol. 63, Iss. 9, pp. 1671-1693
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Type 2 diabetes
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1803-1820
Closed Access | Times Cited: 557
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetes Care (2021) Vol. 44, Iss. 11, pp. 2589-2625
Open Access | Times Cited: 433
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetologia (2021) Vol. 64, Iss. 12, pp. 2609-2652
Open Access | Times Cited: 241
Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care
Nicolas J. Pillon, Ruth J. F. Loos, Sally M. Marshall, et al.
Cell (2021) Vol. 184, Iss. 6, pp. 1530-1544
Open Access | Times Cited: 165
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
Christian Herder, Michael Roden
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1770-1781
Open Access | Times Cited: 92
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Charlotte Ling, Karl Bacos, Tina Rönn
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 433-448
Closed Access | Times Cited: 77
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
Christophe De Block, Clifford J. Bailey, Carol Wysham, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 1, pp. 3-17
Open Access | Times Cited: 71
Type 1 diabetes mellitus: much progress, many opportunities
Alvin C. Powers
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 97
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 66
Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes
Norbert Hermanns, Dominic Ehrmann, Amit Shapira, et al.
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1883-1894
Open Access | Times Cited: 50
Precision prognostics for the development of complications in diabetes
Catarina Schiborn, Matthias B. Schulze
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1867-1882
Open Access | Times Cited: 48
Precision medicine in type 1 diabetes
Alice L. J. Carr, Carmella Evans‐Molina, Richard A. Oram
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1854-1866
Open Access | Times Cited: 40
Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification
Åsa Johansson, Ole A. Andreassen, Søren Brunak, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 378-396
Open Access | Times Cited: 34
Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges
Scott C. Mackenzie, Christopher Sainsbury, Deborah J. Wake
Diabetologia (2023) Vol. 67, Iss. 2, pp. 223-235
Open Access | Times Cited: 22
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review
Jamie L. Felton, María J. Redondo, Richard A. Oram, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Adult-onset autoimmune diabetes
Raffaella Buzzetti, Ernesto Maddaloni, Jason L. Gaglia, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 34
Precision nutrition in diabetes: when population-based dietary advice gets personal
Jordi Merino
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1839-1848
Open Access | Times Cited: 28
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time
Simon Griffin
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1913-1921
Open Access | Times Cited: 28
How caffeic acid and its derivatives combat diabetes and its complications: A systematic review
Iman Akhlaghipour, Arya Nasimi Shad, Vahid Reza Askari, et al.
Journal of Functional Foods (2023) Vol. 110, pp. 105862-105862
Open Access | Times Cited: 20
Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Huixing Liu, Di Fu, Daoquan Peng
Clinical Therapeutics (2023) Vol. 45, Iss. 1, pp. 17-30
Open Access | Times Cited: 18
How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action
Anne‐Marie Baird, C. Benedikt Westphalen, Sandra M. Blum, et al.
Health Science Reports (2023) Vol. 6, Iss. 6
Open Access | Times Cited: 17
Harnessing the power of proteomics in precision diabetes medicine
Nigel Kurgan, Jeppe Kjærgaard Larsen, Atul S. Deshmukh
Diabetologia (2024) Vol. 67, Iss. 5, pp. 783-797
Closed Access | Times Cited: 6
Pharmacogenetics of novel glucose-lowering drugs
Wolfgang Rathmann, Brenda Bongaerts
Diabetologia (2021) Vol. 64, Iss. 6, pp. 1201-1212
Open Access | Times Cited: 33
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children
Amy S. Shah, Kristen J. Nadeau, Dana Dabelea, et al.
Annual Review of Medicine (2022) Vol. 73, Iss. 1, pp. 501-515
Open Access | Times Cited: 26
Time With Diabetes Distress and Glycemia-Specific Distress: New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study
Dominic Ehrmann, Andreas Schmitt, Lilli Priesterroth, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1522-1531
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top